![Jan Spanholtz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jan Spanholtz
Direttore Tecnico/Scientifico/R&S presso Glycostem Therapeutics BV
Provenienza dei contatti di primo grado di Jan Spanholtz
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Glycostem Therapeutics BV
![]() Glycostem Therapeutics BV BiotechnologyHealth Technology Glycostem Therapeutics BV operates as a life science company which develops cellular immunotherapy and production technology platforms. It develops cellular immunotherapeutic for the treatment of leukemia, lymphomas, and other forms of cancer. The firm provides Prototype NK-cell and NK-cell progenitor cell products for clinical evaluations and intervention studies; and GBGM, a cell survival and minimal cellular delineation in expansion and differentiation experiments. The company was founded by Dirk Groenewegen and Jan van der Hoeven in 2007 and is headquartered in Oss, the Netherlands.
4
| Holding Company | Biotechnology | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jan Spanholtz tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
PamGene BV
![]() PamGene BV Pharmaceuticals: MajorHealth Technology PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
University of Hamburg | College/University | Doctorate Degree | |
Delft University of Technology | College/University | Graduate Degree | |
Biox Biosciences BV
![]() Biox Biosciences BV Investment ManagersFinance BioX Biosciences BV (BioX) is an privately owned venture capital firm with its headquarters in s-Hertogenbosch, The Netherlands. The firm was established in 1983. | Investment Managers | Private Equity Investor | |
Wageningen Business Generator BV
![]() Wageningen Business Generator BV Miscellaneous Commercial ServicesCommercial Services Part of Wageningen University, Wageningen Business Generator BV identifies promising opportunities and turns them into thriving businesses. The company is based in Wageningen, Netherlands. | Miscellaneous Commercial Services | President | |
Pepscan Therapeutics BV
![]() Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Isobionics BV
![]() Isobionics BV Chemicals: Major DiversifiedProcess Industries Isobionics BV operates as a holding company, which produces flavor and fragrance ingredients. The firm manufactures and supplies natural chemical substances such as Valencene, Nootkatone, and Beta-Elemene. The company was founded by Toine Janssen in 2008 and is headquartered in Geleen, the Netherlands. | Chemicals: Major Diversified | Director/Board Member | |
InteRNA Technologies BV
![]() InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member | |
Westertoren Innovation Ventures BV
![]() Westertoren Innovation Ventures BV Investment ManagersFinance Westertoren Innovation Ventures BV (Westertoren Innovation Ventures) is a private equity and venture capital subsidiary of Biox Biosciences BV headquartered in 's-Hertogenbosch, Netherlands. The firm was founded in 2009. | Investment Managers | Private Equity Investor Private Equity Investor | |
Streaming Valley BV
![]() Streaming Valley BV Miscellaneous Commercial ServicesCommercial Services Streaming Valley BV provides learning systems for educational purposes. It manufactures presentations 2Go, a comprehensive video platform for recording multi source video and capturing of live events, 360 degree video, management of content, metadata and multi platform streaming. The company was founded by Michaël Hegeman, Hendrik Klompmaker and Oscar Vonder in 2007 and is headquartered in Ede, the Netherlands. | Miscellaneous Commercial Services | Chairman | |
Wageningen University | College/University | Undergraduate Degree Corporate Officer/Principal | |
Newtricious BV
![]() Newtricious BV Food: Major DiversifiedConsumer Non-Durables Newtricious BV develops active food ingredients and products for health maintenance. It focuses on health areas, such as, obesity, metabolic syndrome, eye health, cardiovascular health, and diabetes. The company was founded by Jos Nelissen and Marieëtte Nelissen in 2006 and is headquartered in Oirlo, the Netherlands. | Food: Major Diversified | Director/Board Member | |
LAVA THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
Dutch Life Sciences Coöperatie UA
![]() Dutch Life Sciences Coöperatie UA Miscellaneous Commercial ServicesCommercial Services Dutch Life Sciences Coöperatie UA is a company based in 's-Hertogenbosch, Netherlands. The company provides services to Dutch family offices by onboarding skills in the field of business, intellectual property, finance, and marketing and communication. The company collaborates with specialists to accelerate life sciences and make a difference. The company uses cookies to enhance the user experience on their website and also uses content and scripts from third parties. Eveline Hogenkamp-van Velp has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
Netherlands Translational Research Center BV
![]() Netherlands Translational Research Center BV Medical/Nursing ServicesHealth Services Netherlands Translational Research Center BV develops small molecule drug leads and preclinical candidates for cancer, autoimmune and Parkinson diseases. Its product NFK GreenScreen plays an important role in immune modulation and neurodegenerative disease. The firm also offers Oncolines, OncolinesProfiler, SynergyFinder, ResidenceTimer and EntropySelect services. The company was founded by Guido J. R. Zaman and Rogier C. Buijsman in June 2011 and is headquartered in Oss, the Netherlands. | Medical/Nursing Services | Chairman |
Statistiche
Distribuzione geografica
Paesi Bassi | 17 |
Germania | 2 |
Settori
Health Technology | 6 |
Consumer Services | 4 |
Finance | 4 |
Commercial Services | 4 |
Process Industries | 2 |
Posizioni
Director/Board Member | 12 |
Private Equity Investor | 4 |
Corporate Officer/Principal | 3 |
Chairman | 3 |
Doctorate Degree | 2 |
Contatti più connessi
Insiders | |
---|---|
Jan C. M. van der Hoeven | 11 |
Wim Jongen | 9 |
Dirk Groenewegen | 3 |
Jaeyong Bae | 1 |
- Borsa valori
- Insiders
- Jan Spanholtz
- Connessioni Società